Regulus Therapeutics
RGLS
#8590
Rank
โ‚น11.65 B
Marketcap
โ‚น175.94
Share price
6.19%
Change (1 day)
-5.14%
Change (1 year)

Revenue for Regulus Therapeutics (RGLS)

Revenue in 2024 (TTM): N/A

a decrease over the revenue in the year 2023 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Regulus Therapeutics from 2012 to 2024

Annual revenue

Year Revenue Change
2024 N/A
2023 N/A
2022 N/A
2021 N/A-100%
2020 โ‚น0.73 B50.2%
2019 โ‚น0.48 B9577.32%
2018 โ‚น5.03 M9.51%
2017 โ‚น4.59 M-94.33%
2016 โ‚น81.13 M-94.12%
2015 โ‚น1.37 B183.83%
2014 โ‚น0.48 B-59.8%
2013 โ‚น1.20 B73.86%
2012 โ‚น0.69 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚น3.431 TN/A๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚น4.096 TN/A๐Ÿ‡ซ๐Ÿ‡ท France
โ‚น826.40 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น4.618 TN/A๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚น192.02 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น4.93 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น4.125 TN/A๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น16.47 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA